Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Takeda outlines strategies to expand into India
Takeda’s basic plan consists of the strategies for expanding the Takeda group’s presence in India and at the same time, to pursue productivity and cost-effectiveness as a whole
Takeda’s basic plan consists of the strategies for expanding the Takeda group’s presence in India and at the same time, to pursue productivity and cost-effectiveness as a whole
Previously, Cortex Pharma signed a research agreement with Organon, now a subsidiary of Merck, providing Organon an exclusive, worldwide right to develop and commercialise the schizophrenia and depression
Prior to being named as Rondaxe Enterprises’ CEO, Shultis was responsible for the company’s Software Development and Pharma Consulting groups, where he oversaw a myriad of services including
The total contract value for Galapagos for the initial phase of the collaboration could exceed €33.5m over a 5 year period pending the achievement of certain milestones. As
The grant is expected to support the next stages of development for Embera’s drug candidate EMB-001 to treat cocaine dependence, as well as advance EMB-001 into clinical testing.
Elan said that its Manufacturing Services offers an advantage in outsourcing, including a broad range of services and expertise integrated to one company that is based in the
Cook has over 15 years of business experience and has expertise in corporate finance, private equity and corporate management, and brings a combination of skills and experience to
The grant was awarded to Maven through the federal stimulus package initiative for Biomedical Research, Development, and Growth to Spur the Acceleration of New Technologies (BRDG-SPAN). The target
Under the contract, NovaBiotics is expected to work on peptide selection and maturation with Isogenica to expand its product portfolio. NovaBiotics founder Deborah O’Neil said that Isogenica’s experts
Parexel already has offices in Tokyo and Kobe. Parexel now has 18 offices throughout important biopharmaceutical centers in the Asia/Pacific region, including Japan, Australia, China, India, Indonesia, Malaysia,